肝硬化患者心脏手术(CASTER)研究:早期与长期结局
该回顾性队列研究纳入2000至2017年意大利10家机构144例接受心脏手术的肝硬化成人患者,按CTP和MELD评分分层。结果显示术后并发症随CTP分级加重而显著恶化,观察死亡率较EuroSCORE II预测高3至4倍,但早期CTP分级患者中期生存可接受。
要点
- 肝硬化患者心脏手术后观察死亡率较EuroSCORE II预测高3至4倍。
- 晚期CTP B级患者术后并发症(急性肾损伤、肝脏并发症、住院时间)显著恶化。
- CTP A级和早期B级患者5年生存率分别为72%±5%和68%±11%。
核心结论
- 肝硬化患者心脏手术结局与术前肝功能障碍程度相关,早期CTP分级患者中期生存可接受。
研究设计与样本
- 回顾性队列研究,纳入2000至2017年意大利10家机构144例接受心脏手术的肝硬化成人患者,按CTP和MELD评分分层分析早期和中期结局。
主要发现
- 总体观察死亡率较EuroSCORE II预测死亡率高3至4倍,各亚组亦如此。
- 术后并发症(尤其急性肾损伤、肝脏并发症和住院时间)在晚期CTP B级(MELD>12)显著恶化(P=.001)。
- 总体1年和5年累积生存率分别为82%±3%和77%±4%。
- CTP A级、早期B级和晚期B级的5年生存率分别为72%±5%、68%±11%和61%±10%(P=.238)。
关键数值与推荐
- 主要肝硬化病因:病毒性43%,酒精性36%。
- 手术类型:冠状动脉旁路移植术36%,瓣膜手术50%(其中87%为生物瓣)。
临床怎么用
- 术前应使用CTP和MELD评分对肝硬化患者进行风险分层,尤其关注晚期CTP B级患者术后并发症风险。
- 对早期CTP分级患者,心脏手术中期生存可接受,但需告知观察死亡率高于EuroSCORE II预测。
局限性
- 回顾性研究设计。
- 样本量较小(144例),尤其早期和晚期CTP B级亚组样本量有限。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Patients with liver cirrhosis (LC) undergoing cardiac surgery (CS) face perioperative high mortality and morbidity, but extensive studies on this topic are lacking. METHODS: All adult patients with LC undergoing a CS procedure between 2000 and 2017 at 10 Italian Institutions were included in this retrospective cohort study. LC was classified according to preoperative Child-Turcotte-Pugh (CTP) score and Model for End-Stage Liver Disease (MELD) score. Early-term and medium-term outcomes analysis was performed in the overall population and according to CTP classes. RESULTS: The study population included 144 patients (mean age 66 ± 9 years, 69% male). Ninety-eight, 20, and 26 patients were in CTP class A, in early CTP class B (MELD score <12), or advanced CTP class B (MELD score >12), respectively. The main LC etiologies were viral (43%) and alcoholic (36%). Liver-related clinical presentation (ascites, esophageal varices, and encephalopathy) and laboratory values (estimated glomerular filtration rate, serum albumin, and bilirubin, platelet count) significantly worsened across the CTP classes (P = .001). Coronary artery bypass grafting or valve surgery (87% bioprosthesis) were performed in 36% and 50%, respectively. Postoperative complications (especially acute kidney injury, liver complication, and length of stay) significantly worsened in advanced CTP class B (P = .001). Notably, observed mortality was 3-fold or 4-fold higher than the EuroSCORE (European System for Cardiac Operative Risk Evaluation) II-predicted mortality, in the overall population, and in the subgroups. At Kaplan-Meier analysis, 1-year and 5-year cumulative survival in the overall population was 82% ± 3% and 77% ± 4%, respectively. The 5-year survival in CTP class A, early CTP class B, and advanced CTP class B was 72% ± 5%, 68% ± 11%, and 61% ± 10%, respectively (P = .238). CONCLUSIONS: CS outcomes in patients with LC are significantly affected in relation to the extent of preoperative liver dysfunction, but in early CTP classes, medium-term survival is acceptable. Further analysis are needed to better estimate the preoperative risk stratification of these patients.
引用
- Garatti A, Daprati A, Cottini M, et al. Cardiac Surgery in Patients With Liver Cirrhosis (CASTER) Study: Early and Long-Term Outcomes. Ann Thorac Surg. 2020. PMID: 32919974. doi:10.1016/j.athoracsur.2020.06.110
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。